Sema Aktaş1, Şinasi Sevmiş1, Mehmet Şeker2, Esin Korkut3, Hamdi Karakayalı1

1Department of General Surgery, Medipol University School of Medicine, İstanbul, Turkey
2Department of Radiology, Medipol University School of Medicine, İstanbul, Turkey
3Department of Gastroenterology, Medipol University School of Medicine, İstanbul, Turkey


Objective: As might be expected, living donor liver surgery is associated with serious morbidity and mortality risks. Coagulopathy after donor hepatectomy is an important risk factor affecting morbidity. In this study, risk factors affecting the development of coagulopathy after donor hepatectomy was evaluated in a newly-established liver transplant center.
Material and Methods: A retrospective evaluation of 46 liver donors to whom hepatectomy was applied in Medipol Universty of School of Medicine Department of Organ Transplantation between April 2014 and July 2015 was made. Coagulopathy was defined as prothrombin time ≥15 sec. or platelet count <80000/mm3 on postoperative day 3. Donors were separated into 2 groups as those with (n=24) and without (n=22) coagulopathy. Preoperative, intraoperative and postoperative factors acting on coagulopathy were analyzed.
Results: In the intergroup analysis, it was seen that remnant liver volume, remnant liver volume % and remnant liver volume to body weight ratio were factors associated with coagulopathy. The cut-off values for these 3 parameters were calculated as 773.5cm3, 40.5% and 0.915 cm3/kg, respectively. Only remnant liver volume % was determined as a risk factor for coagulopathy after donor hepatectomy on multiple logistic regression analysis.
Conclusion: The results of this study showed that the most important risk factors affecting coagulopathy after donor hepatectomy were the parameters associated with remnant liver volume.

Keywords: Donor hepatectomy, coagulopathy, remnant liver, risk factors

Cite this paper as: Aktaş S, Sevmiş Ş, Şeker M, Korkut E, Karakayalı H. Analysis of risk factors affecting coagulopathy after donor hepatectomy in a newly established liver transplant center. Turk J Surg 2017; 33(2): 69-75


Ethics Committee Approval

Authors declared that the research was conducted according to the principles of the World Medical Association Declaration of Helsinki “Ethical Principles for Medical Research Involving Human Subjects”. (amended in October 2013).

Peer Review

Externally peer-reviewed.

Author Contributions

Concept - S.A.; Design - Ş.S.; Supervision - H.K.; Resource - S.A., Ş.S.; Materials - S.A., Ş.S.; Data Collection and/or Processing - Ş.S., E.K., M.Ş.; Analysis and/or Interpretation - Ş.S.; Literature Search - S.A.; Writing Manuscript - S.A.; Critical Reviews - H.K.

Conflict of Interest

No conflict of interest was declared by the authors.

Financial Disclosure

The authors declared that this study has received no financial support.